PRICE T ROWE ASSOCIATES INC /MD/
Position in SRRK — Scholar Rock Holding Corp
CIK 80255
BALTIMORE, MD
Position in SRRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$373,716,035
+$68,598,695 QoQ
Shares Held
6,794,837
+9.5% QoQ
Ownership
5.58%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#5
of 302 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. SRRK ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
This page
|
6,794,837 | $373,716,035 |
All Filings in SRRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $373,716,035 | 6,794,837 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $305,117,340 | 6,206,618 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $282,027,349 | 6,402,437 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $256,325,079 | 6,883,058 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $310,337,642 | 8,761,650 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $285,938,434 | 8,893,886 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $401,229,454 | 9,283,421 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $69,319,388 | 8,654,106 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $68,207,097 | 8,188,127 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $145,776,086 | 8,208,113 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $156,443,654 | 8,321,471 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $50,920,858 | 7,171,952 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $53,421,675 | 7,085,103 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $57,689,312 | 7,211,164 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $63,666,930 | 7,035,020 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $47,873,423 | 6,908,142 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $46,314,655 | 8,436,185 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $73,882,167 | 5,731,743 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $130,723,008 | 5,262,601 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $173,135,780 | 5,243,361 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $139,299,069 | 4,820,037 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $222,237,770 | 4,386,849 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $193,949,853 | 3,996,494 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $41,728,516 | 2,358,876 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $23,431,936 | 1,286,762 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $16,180,691 | 1,336,143 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||